Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-09

Clinical Trial Update: Pazopanib Maintenance Phase II [Phase 2]

View source ↗

Summary

A Phase 2 maintenance trial of pazopanib in patients with sarcoma was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazopanib (Pazopanib)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2024-08-09